Ergoteles’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-13,850
| Closed | -$137K | – | 2087 |
|
|
2022
Q3 | $137K | Hold |
13,850
| – | – | ﹤0.01% | 1299 |
|
|
2022
Q2 | $136K | Hold |
13,850
| – | – | ﹤0.01% | 1443 |
|
|
2022
Q1 | $137K | Hold |
13,850
| – | – | 0.01% | 1069 |
|
|
2021
Q4 | $139K | Hold |
13,850
| – | – | 0.01% | 1105 |
|
|
2021
Q3 | $138K | Hold |
13,850
| – | – | 0.01% | 1066 |
|
|
2021
Q2 | $139K | Hold |
13,850
| – | – | ﹤0.01% | 1355 |
|
|
2021
Q1 | $137K | Buy |
+13,850
| New | +$137K | ﹤0.01% | 714 |
|